- Home
- VNDA vs KGEI Comparison
VNDA vs KGEI Comparison
Compare VNDA & KGEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- KGEI
- Stock Information
- Founded
- VNDA 2002
- KGEI 2008
- Country
- VNDA United States
- KGEI United States
- Employees
- VNDA N/A
- KGEI N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- KGEI
- Sector
- VNDA Health Care
- KGEI
- Exchange
- VNDA Nasdaq
- KGEI Nasdaq
- Market Cap
- VNDA 237.9M
- KGEI 262.6M
- IPO Year
- VNDA 2006
- KGEI N/A
- Fundamental
- Price
- VNDA $4.22
- KGEI $5.81
- Analyst Decision
- VNDA Strong Buy
- KGEI Strong Buy
- Analyst Count
- VNDA 2
- KGEI 1
- Target Price
- VNDA $16.50
- KGEI $11.00
- AVG Volume (30 Days)
- VNDA 500.0K
- KGEI 86.7K
- Earning Date
- VNDA 05-07-2025
- KGEI 05-16-2025
- Dividend Yield
- VNDA N/A
- KGEI N/A
- EPS Growth
- VNDA N/A
- KGEI N/A
- EPS
- VNDA N/A
- KGEI 0.50
- Revenue
- VNDA $201,351,000.00
- KGEI $58,651,000.00
- Revenue This Year
- VNDA $14.36
- KGEI $32.19
- Revenue Next Year
- VNDA $44.53
- KGEI $33.24
- P/E Ratio
- VNDA N/A
- KGEI $12.04
- Revenue Growth
- VNDA 13.37
- KGEI 15.91
- 52 Week Low
- VNDA $3.85
- KGEI $2.85
- 52 Week High
- VNDA $6.75
- KGEI $9.89
- Technical
- Relative Strength Index (RSI)
- VNDA 41.17
- KGEI 32.76
- Support Level
- VNDA $4.20
- KGEI $6.70
- Resistance Level
- VNDA $4.64
- KGEI $7.29
- Average True Range (ATR)
- VNDA 0.17
- KGEI 0.40
- MACD
- VNDA 0.01
- KGEI -0.09
- Stochastic Oscillator
- VNDA 20.75
- KGEI 0.00
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About KGEI Kolibri Global Energy Inc. Common stock
Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. Its segments include the United States, Canada and Others. The company derives a majority of its revenue from the United States.